Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134641) titled 'Multimodal Artificial Intelligence (Pathology-Immunohistochemistry-Imaging) for Predicting Immunotherapy Efficacy in Cholangiocarcinoma: Model Construction and Multicenter Validation' on Oct. 19.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine
Condition:
cholangiocarcinoma
Intervention:
Retrospective study:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-20
Target Sample Size: Retrospective study:1000;Prospective validation:200;
Countries of Recruitment:
China
To ...